Literature DB >> 18546201

Cdk9-55: a new player in muscle regeneration.

Cristina Giacinti1, Antonio Musarò, Giulia De Falco, Isabelle Jourdan, Mario Molinaro, Luigi Bagella, Cristiano Simone, Antonio Giordano.   

Abstract

Adult skeletal muscle contains a specialized population of myogenic quiescent stem cells, termed satellite cells, which contribute to repair myofibers after injury. During muscle regeneration, satellite cells exit their normal quiescent state, proliferate, activating MyoD and Myf-5 expression, and finally differentiate and fuse to reconstitute the injured muscle architecture. We have previously reported that cdk9 is required for myogenesis in vitro by activating MyoD-dependent transcription. In myoblasts induced to differentiate, MyoD recruits cdk9 on the chromatin of muscle-specific regulatory regions. This event correlates with chromatin-modifying enzyme recruitment and phosphorylation of cdk9-specific target residues at the carboxyl-terminal domain of RNA polymerase II. Here we report that a second cdk9 isoform, termed cdk9-55, plays a fundamental role in muscle regeneration and differentiation in vivo. This alternative form is specifically induced in injured myofibers and its activity is strictly required for the completion of muscle regeneration process.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18546201     DOI: 10.1002/jcp.21361

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  10 in total

1.  HEXIM1 controls satellite cell expansion after injury to regulate skeletal muscle regeneration.

Authors:  Peng Hong; Kang Chen; Bihui Huang; Min Liu; Miao Cui; Inna Rozenberg; Brahim Chaqour; Xiaoyue Pan; Elisabeth R Barton; Xian-Cheng Jiang; M A Q Siddiqui
Journal:  J Clin Invest       Date:  2012-11       Impact factor: 14.808

2.  Phosphorylation of histone H1 by P-TEFb is a necessary step in skeletal muscle differentiation.

Authors:  Siobhan K O'Brien; Kendall L Knight; Tariq M Rana
Journal:  J Cell Physiol       Date:  2012-01       Impact factor: 6.384

3.  The myogenic kinome: protein kinases critical to mammalian skeletal myogenesis.

Authors:  James Dr Knight; Rashmi Kothary
Journal:  Skelet Muscle       Date:  2011-09-08       Impact factor: 4.912

4.  A Network of Regulations by Small Non-Coding RNAs: The P-TEFb Kinase in Development and Pathology.

Authors:  Hossein Ghanbarian; Valérie Grandjean; François Cuzin; Minoo Rassoulzadegan
Journal:  Front Genet       Date:  2011-12-28       Impact factor: 4.599

5.  Up-regulation of CDK9 kinase activity and Mcl-1 stability contributes to the acquired resistance to cyclin-dependent kinase inhibitors in leukemia.

Authors:  Yuh-Ying Yeh; Rong Chen; Joshua Hessler; Emilia Mahoney; Amy M Lehman; Nyla A Heerema; Michael R Grever; William Plunkett; John C Byrd; Amy J Johnson
Journal:  Oncotarget       Date:  2015-02-20

6.  Abnormal epigenetic changes during differentiation of human skeletal muscle stem cells from obese subjects.

Authors:  Cajsa Davegårdh; Christa Broholm; Alexander Perfilyev; Tora Henriksen; Sonia García-Calzón; Lone Peijs; Ninna Schiøler Hansen; Petr Volkov; Rasmus Kjøbsted; Jørgen F P Wojtaszewski; Maria Pedersen; Bente Klarlund Pedersen; Dov B Ballak; Charles A Dinarello; Bas Heinhuis; Leo A B Joosten; Emma Nilsson; Allan Vaag; Camilla Scheele; Charlotte Ling
Journal:  BMC Med       Date:  2017-02-22       Impact factor: 8.775

7.  P-TEFb- the final frontier.

Authors:  Jiri Kohoutek
Journal:  Cell Div       Date:  2009-09-02       Impact factor: 5.130

Review 8.  CDK9 keeps RNA polymerase II on track.

Authors:  Sylvain Egloff
Journal:  Cell Mol Life Sci       Date:  2021-06-19       Impact factor: 9.261

9.  Deregulations in the cyclin-dependent kinase-9-related pathway in cancer: implications for drug discovery and development.

Authors:  Gaetano Romano
Journal:  ISRN Oncol       Date:  2013-06-06

Review 10.  PRC2: an epigenetic multiprotein complex with a key role in the development of rhabdomyosarcoma carcinogenesis.

Authors:  Stefano Zoroddu; Irene Marchesi; Luigi Bagella
Journal:  Clin Epigenetics       Date:  2021-08-09       Impact factor: 6.551

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.